Related Experiment Video
Updated: Jul 7, 2026
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report
Darrell S Rigel1, Abel M Torres, Haines Ely
1Clinical Professor of Dermatology, New York University School of Medicine, New York, NY, USA.
Background:
Using more than one therapeutic approach in the treatment of basal cell carcinomas (BCCs) has the potential to enhance cure rates.
Materials And Methods:
In this study, 57 nodular and superficial BCCs were curetted without electrodesiccation. One week later, imiquimod 5% cream therapy was initiated once daily 5 times per week for 6 weeks. At 1-year follow-up, 0 of 57 BCCs (0%) had clinical recurrences. Cosmetic results were very good to excellent.
Conclusion:
Combination therapy with imiquimod 5% cream followed by curettage represents an effective method for treating BCCs with a high cure rate.
Related Concept Videos
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:19Clinical Applications of Epidermal Stem Cells